The Institute of Cancer Research, made the following remark on Twitter:
“Our scientists have looked into better understanding why patients with triple negative breast cancer respond differently to treatment, in a new study run by The Institute of Cancer Research Clinical Trials and Statistics Unit.
The findings could help accelerate the development of more personalised treatments.”
For full article: Click here
Source: The Institute of Cancer Research / Twitter